Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
if your interested in our FDA cheif see link:
http://www.fda.gov/AboutFDA/CentersOffices/ucm193998.htm
Dr. Hamburg and Husband Peter Brown, hedge fund mngr. & CO-CEO of Renaissance Technologies Corp. divested personal holdings in big pharma worth 30mil. after Dr. Hamburg accepted position as Cheif of FDA.
awesome assessment !!
There was information recently, Roskamp/RCP are running a clinical trial on the delayed release version , there is a public recruitment at this time, they aren't accepting Anatabloc users at this time, I would have sign up.
I like funny, I agreed with everything leif said. What's laughable is that anyone would think there isn't hidden agendas at work behind the seen. That those who have the most to lose aren't doing whatever they can to discourage the competition.
Well said!!! I agree totally.
We need to ask our representatives to contact the FDA with our concerns, and demand that the FDA does not in anyway prohibit our access and use of Anatabloc. So many of us are benefiting from Anatabloc, many are elderly, stopping our use would be very wrong. The job of our representative is to help us in dealing with Government agencies, they will help, with our representative helping there's enough of us to incline the FDA to act in our interest. Engage your representative, we have power, we've put our money on it and we are right about Anatabloc.
For a simple outline, search google: Writing a Letter to Your Member of Congress. This is helpful, but mail is slow due to increased security. Or you can email your representative directly from their web site: house.gov/representatives/#state_fl
I am following up with a letter in the mail.
I agree with nuke, we should get our congress person involved also. The FDA would take more interest in us if congress is calling and inquiring about the case.
email Quyen T. Tien at: quyen.tien@fda.hhs.gov ph. 215-717-3705
leif, I just tried sending my email letter Ms Robinson, this time I didn't use capitals and I dropped the period, like this:
latasha.robinson@fda.hhs.gov
She received it and this is the auto reply she sent:
I will be out of the office December 31, 2013-January 3, 2014, returning to the office January 6, 2014. I will not have access to my email. For issues related to dietary supplements, please contact Quyen Tien and for all other matters, please contact Carrie Lawlor.
I'm no attorney, though, the article anatabine is a "dietary ingredient" in certain vegetables, a botanical and obviously such food has been sold prior to marketing Anatabloc and prior to Oct 15, 1994. I'd argue for exception from a "new dietary ingredient" designation. The FDA will want to clear Anatabine based on it's benefit to mankind. They need to hear from the public, public opinion comes from we the users, get the word to the FDA, your reports and benefits after using Anatabloc, let the FDA know you would be at a loss with out Anatabloc, I would be. I think it is obvious that anatabine will be a huge benefit as a drug as well as a nutraceutical. The worst thing we could do is stay silent by not going out to the FDA about our approval of Anatabloc.
I agree, my letter will be in the mail tomorrow, the email address to Latasha doesn't work so my letter is going by us mail. My congressman will get a copy also.
Thank you for the notes.
what does this mean? would you explain?
My information is from the consent form sent to me via email from Kelly Rodrigo Clinical Trials Coordinator at Rosekamp. I don't have a link to offer you.
The clinical trial is a tolerability study of ascending doses of a sustained release formulation of anatabine in healthy volunteers. The trial runs 10 weeks with assessment one week after finishing.
I don't know but wouldn't he have to file a SEC form when he sells?
Can he unload his shares in secret?
Nuke, I have been followed this board a short time, all the while you and others have shown indisputable scientific proof that transcription of NF-kB causes the vicious cycle of chronic low grade inflammation in the body. Which than causes pathogenesis of at least seven major disease. Also a leading cause of mortality and aging. I am amazed by all the finding, and that Anatabloc regulated the vicious cycle. Even more amazed that Wall Street hasn't caught on to this miracle remedy. They still think Anatabloc is snake oil. A RCP drug will be a major game changer. The value of a drug that regulates inflammation is mind boggling. I am thankful I can use Anatabloc without a prescription it has improved my life and life of my wife.
of the virtues of Anatabloc. Today's post is another example of great work
Leif, this was helpful, thank you.
mugs, yeah Florida, bring it to Dr Mullen and team. The VA head hunters can... well I won't go there.
Nuke, I see your point, Dr Mullen made known his plan and vision, quite accurately. Five years later he is CEO of a for profit company, Rock Creek Pharmaceutical. It seems Dr Mullan has made preparations for his new position, he already has certain experience running a pharmaceutical co. He believes his cocktail drug will best treat Alzheimer's, Phase 3 clinical trials on Nilvadipine are underway in Europe. Anatabine citrate, Anatabloc is a excellent anti inflammatory product for the cocktail. I think it is understood that Nilvadipine and Anatabine Citrate will likely make up the cocktail, I hope Dr Mullen will share that news with us soon. What about team Mullen and "MS", would that be near term.
What will he say next? Will he address the stockholders this month? Stockholders are desperate to hear from the new management. Good news from Dr Mullen about his cocktail should move the stock, don't you think? I think the stock will be a winner.
Nuke, it does appears that important developments are coming together for long waited shareholders & Anatabloc. Dr Mullen takes control at Rock Creek Pharmaceutical, Phase 2 Clinical trial milestones are reached. A favorable FDA designations may be next, the request should be made during phase 2 meeting see excerpt below. The Dec.27th share holders meeting could be revealing.
The link in your post showed details from FDA Breakthrough Therapy Expedited Approval process.
Document titled: Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review
Expediting Availability of New Drugs for Patients with Serious Conditions
excerpt..
Ideally, a Breakthrough Therapy designation request should be received by FDA no later than the end-of-phase-2 meetings if any of the features of the designation are to be obtained.
The Rockcreek/Rosekamp Phase 2 Alzheimer's study is reaching important dates...
ClinicalTrials.gov Identifier:
NCT01669876
excerpt..
Estimated Enrollment: 200
Study Start Date: August 2012
Estimated Study Completion Date:February 2014
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Per your post the FDA has stated: The preliminary clinical evidence should show a clear advantage over available therapy. Could Dr Mullan soon announce that his anatabine citrate cocktail to treat Alzheimer's does that.
I remain hopeful and more optimistic than ever.
Nuke, thank you for your thoughts, your right, I want to keep those points in mind. I hope Patrick Cox will have more about the superiority of Anatabloc verses the other NF-kB inhibitor competitors, if there are any. His support group at Mauldin is doing traditional analysis on STSI and he will be writing a great deal about the product, company and management, after the Holiday my guess.
I am also seeing benefit from Anatabloc, I've used it going on two years and I am a share holder.
When I Google search NF-KB blockers I see a number of known NF-KB blockers. See link:
NF kappa B Inhibitors - Santa Cruz Biotechnology
www.scbt.com › Chemicals?
Couldn't another blocker, perhaps one from the Santa Cruz list be a prime candidate for pharmaceutical use. Can we rightly think Anatabloc has something better, or more advantageous. Does anyone have insight on this concern.
That's all he wrote about Anatabloc, he didn't write anything about Star. He write for Mauldin Economics.
He hasn't reported on Star yet, I'm waiting for him to cover Star in upcoming issues. I'm guessing though.
Cox wrote in his weekly update today.
I'm late with my monthly edition and I've got to take my regular Anatabloc dose, so I'm cutting this short. I don't think, in fact, that either my wife or I have missed more than a dose or two in the last two years.
For transformational profit,
Patrick Cox
As for coffee, Starbloc & Starbucks get a little confusing, the rest works just fine.
Not bad! do you mean change the name with the roll out of the better time release version?
good posting, your professionalism is a benefit here. I'm a little fish looking to cash out, I'll wait a few more years for payday. I'm in high at 3.5, I'd like to load up today if I could. I want to hear from the CEO, maybe in January!
You could be right about that, I hadn't considered that thought.
It takes time for Anatabloc to do it's work. I didn't feel any benefit at first then in the second month I began to feel better and I've seen my skin condition clear up. I feel better and will continue to use it. The trouble is unless people see or feel improvement in a few weeks they doubt it will benefit their health, they think it's to expensive.IMO
For sales to go up faster marketing has to do a better job. The challenge is for marketing. Increased sales through user word of mouth will remain slow. IMO
Anyone on this board can say Abloc doesn't work, the naysayers are wrong, the science is proven, it's a fact, it works with inflammatory conditions of autoimmune disorders.
The single isomer is a potential blockbuster. The pharmaceutical use of anatabine will further validate the benefits of Anatabloc, skeptic will become believers and users of Anatabloc. It should be great for the neutraceutical business. IMO
Friday Dec 27th at 11:AM. Can any one tell me how I can get a Proxy Card to vote?
(S.T.Light) Your opinion has encouraged me, I think we will have more facts soon. Dr Mullen's team could already have the MOA for Thyroid, they undoubtedly have expertise to solve that problem. I am anxious to hear from the new CEO, it will be interesting. At this time there's still a lot of risk with Star, though Stars future is improving.IMO
Great post, your insight, logic and reasoning makes good sense. Do you or anyone else have an idea of when the isomer version will be completed? And then how long will the FDA approval take?
In para.3, Re: the potential partner for Thyroid, you state that remaining steps are necessary to get FDA approval, are you referring to the isomer?
Thank you!
Can you explain further why the CRP is as you say?
The report details show: significantly greater percentage of patients in the anatabine group (filled columns) had reductions in TgAb of at least 25, 50,75, and 100 WHO units at week 12 relative to placebo (open columns).
Thank you for given your brief summery of the important on going developments of anatabine citrate. Anatabloc is truly the most remarkable product, it has so many uses for safe treatment for ailment and illness surrounding inflammation.
There's little doubt, given time, Anatabloc or a better formulation of, will be benefiting people Worldwide. It is exciting to me because I use it, I know that it works, it is wonderful and I advise and encourage others to use it.
Important changes underway at Star/Rockcreek are pro development. The new management has impressive technical expertise, a perfect fit for Star/Rockcreek at this time. Anatabloc provides real benefit, its factual now and the facts continue to be proven.
The Anatabloc discovery and future products are to important to fall by the wayside, that is why I believe in Star/Rockcreek, now is the time.
Some of the poster on this board want the share price to go down, they are negative. They'll go away sooner or later, it will be fun when their gone.
I chew up the unflavored tabs like it's candy, they taste good. If your using 1 or 2 a day your not benefit from a full daily dose based on your weight. See the table on bottle, a 120 lb person can take 2 tabs 3 times a day. The table is hard to read because of the size of the print, I need a magnifying glass to read it.
I'm afraid that you may be right, a collaboration with big pharma is what is needed. With excellent new management taking over that becomes a real possibility. Dilution isn't the solution nor is another infusion from JW.
I've got it, I'm remembering the lesson, thanks for the reply!
I'd guess, investors who were holding for a pop on the peer review or on a buy out sold today. They couldn't wait for the new plan to develop. Today's news is a game changer, will today's developments draw in buyers at this level, I would think so, but I don't have expertise. The next few weeks will be interesting. Can we ask the fund managers or the other professionals. Somebody should be beating the drum to the funds and brokerages.